ANI | Updated: Jan 17, 2021 23:38 IST
Washington [US], January 17 (ANI): A new research has indicated that itching often doesn t respond to antihistamines because the itch signals are being carried to the brain along a previously unrecognized pathway that current drugs don t target.
New research from Washington University School of Medicine in St. Louis indicates that allergens in the environment often are to blame for episodes of acute itch in eczema patients.
The new findings, published in the journal Cell, point to a possible new target and strategy to help eczema patients cope with those episodes of acute and severe itch. Years ago, we used to think that itch and pain were carried along the same subway lines in the nerves to the brain, but it turned out they weren t, and these new findings show there s another pathway entirely that s causing these episodes of acute itching in eczema patients, said principal investigator Brian S. Kim, M
Study shows why antihistamine drugs fail to control severe itch in eczema patients
In addition to a skin rash, many eczema sufferers also experience chronic itching, but sometimes that itching can become torturous. Worse, antihistamines the standard treatment for itching and allergy often don t help.
New research from Washington University School of Medicine in St. Louis indicates that allergens in the environment often are to blame for episodes of acute itch in eczema patients, and that the itching often doesn t respond to antihistamines because the itch signals are being carried to the brain along a previously unrecognized pathway that current drugs don t target.
Acute Itching in Eczema Patients Linked to Environmental Allergens Details 15 January 2021
Share This
In addition to a skin rash, many eczema sufferers also experience chronic itching, but sometimes that itching can become torturous.
In addition to a skin rash, many eczema sufferers also experience chronic itching, but sometimes that itching can become torturous. Worse, antihistamines the standard treatment for itching and allergy often don’t help.
New research from Washington University School of Medicine in St. Louis indicates that allergens in the environment often are to blame for episodes of acute itch in eczema patients, and that the itching often doesn’t respond to antihistamines because the itch signals are being carried to the brain along a previously unrecognized pathway that current drugs don’t target.
Share this article
Share this article
BERKELEY, Calif., Jan. 15, 2021 /PRNewswire/ The COVID-19 Early Treatment Fund (CETF) announced today that the use of the generic antidepressant fluvoxamine helped speed the recovery of dozens of COVID-infected workers at Golden Gate Fields, the Berkeley horse racing venue that reopened Friday.
The track physician, Dr. David Seftel, offered fluvoxamine to infected employees after learning about the 100% success rate in avoiding hospitalization in a Phase 2 randomized controlled trial published on November 12, 2020, in the Journal of the American Medical Association. None of the 77 employees at Golden Gate Fields who opted to take fluvoxamine required hospitalization, compared with a 12.5% hospitalization rate for the 48 employees who declined the drug.